Results per Page:
The Beam: Proton therapy for sarcomas; radiation oncology residency program
Can proton therapy benefit sarcoma patients? What are residencies, and why are they important in health care?
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Outstanding people are the Heart of the Hutch
Fred Hutch clinical and admin teams share their passion for helping patients, faculty
Dr. Elizabeth Loggers recognized as national palliative care leader
Expertise helps her better support and care for patients with sarcoma
Proton therapy — and a pet cat — help young animal lover through chondrosarcoma treatment
Young patient with rare cancer wants to help others deal with cancer treatment and other life challenges
Using a mouse model to combat the effects of lipodystrophy
From the Kensler Lab, Public Health Sciences Division
CAF-like cells remodel the Ewing sarcoma tumor microenvironment
From the Lawlor lab, Seattle Children’s Hospital and the Cancer Basic Biology Program of the Cancer Consortium
Immunotherapy helps retired fisheries biologist get back to normal
Advanced chondrosarcoma – 'shark' cancer – has no standard treatments beyond surgery, but Fred Hutch oncologist explores new option for patient
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
For a young woman who wanted children, proton therapy was the solution
Proton therapy spared Jane's healthy reproductive tissue during treatment for sarcoma.
Global collaborators at the Heart of the Hutch
Advancing science to address the burden of cancer in low- and middle-income countries
In Uganda: Treating twin threats of HIV and cancer
Dr. Sue Desmond-Hellmann of the Bill & Melinda Gates Foundation visits Hutch researchers in Kampala
Interferon gamma brings the heat to cold tumors
From the Pollack Lab, Clinical Research Division
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Good News: Dr. Gary Gilliland speaks to members of Congress about federal research funding
Celebrating faculty and staff achievements
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Using a virus to teach the immune system to kill cancer
‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Q&A with the author of ‘The Radium Girls’: A new story chronicles century-old fight for workplace safety
Author Kate Moore in conversation with cancer researcher Dr. Anne McTiernan